January 22, 2020 Internal FDA documents reveal a familiar story for Sarepta The unexpected approval of Vyondys 53 followed an FDA power struggle, and turned on a vague commitment from Sarepta, it has emerged.
January 18, 2019 US regulator wipes the smile off Immunomedics’ face Issues with manufacturing, not exactly a new problem for Immunomedics, derail the company’s bid for glory.
May 04, 2018 Snippet roundup: The good times roll for Moderna, but Mallinckrodt and Smith & Nephew flag
